Please join Ortho Clinical Diagnostics for our educational workshop and the informative sessions at the IFCC 1st Virtual Conference on Critical Role of Clinical Laboratories in COVID-19 Pandemic:
Educational Workshop
Role of Antigen Tests in the COVID-19 pandemic
Date & Time: Wednesday 17 February 14:15 - 15:15 EST (20:15 - 21:15 CET)
Speakers:
![](https://www2.orthoclinicaldiagnostics.com/l/417052/2020-12-30/5zcngw/417052/16093447417dntQKcj/karen_roush.jpg)
Dr. Karen Roush, MD, MBA
Dr. Roush holds several positions within the Methodist Health System in the Dallas, Texas area, including Vice Chair, Department of Pathology and Medical Director for Pathology, Transfusion Services, and the Transplant Immunology Laboratory. She also serves on several committees across the Methodist Health System. She is the author of several books and book chapters on the topic of blood banking and transfusion medicine in addition to articles that have been published in peer-reviewed journals.
Content:
- Challenges with RT-PCR testing for SARS-CoV-2
- SARS-CoV-2 and infectiousness – what do we know today?
- Performance data of a high throughput SARS-CoV-2 antigen test
- Implementing a high throughput SARS-CoV-2 test at a large metropolitan medical center
- Algorithms used to determine when to order which SARS-CoV-2 test
- Workflow and clinical performance with the VITROS SARS-CoV-2 Antigen test
![](https://www2.orthoclinicaldiagnostics.com/l/417052/2020-11-24/5yxf94/417052/1606225687LJUFzlAk/speaker_lily.jpg)
Dr. Lily Li, MD, PhD, MBA
Dr. Lily Li is the Medical Safety Officer at Ortho Clinical Diagnostics responsible for evaluating potential medical risks and guiding risk mitigation of all marketed products. She also serves as a Director at Medical and Scientific Affairs providing evidence-based support to Ortho’s current and future products. Prior to Ortho, Lily had ten years of pharmaceutical R&D experience in Johnson & Johnson and led and advanced multiple programs of biologics or cell therapy through development. Lily obtained her Medical Degree from Peking University, China, and her Ph.D. in Immunology from the University of Alberta, Canada. She completed her post-doctoral training at the Scripps Research Institutes, San Diego. Lily is the author of more than 40 scientific articles and filed 17 patent applications. Lily also obtained her MBA from Temple University.
Industry Panel
How are SARS-CoV-2 antigen and antibody tests impacted (or not) by the mutations of the virus?
Date & Time: Tuesday 16 February 9:30 - 12:00 EST (15:30 - 18:00 CET)
Speaker:
Patric Lundberg, PhD
Senior Scientist in the Research and Development department at Ortho Clinical Diagnostics.
Patric received his doctorate in Molecular and Cellular Biology from the University of Wisconsin – Madison studying retroviral immunology. His expertise is in immunology, virology and bioinformatics surrounding viral pathogenesis and has received funding and published in these and other areas beyond viral immunology. Since Fall 2020, he joined the Infectious Disease division of Ortho Clinical Diagnostics and has been involved in SARS-CoV-2 mutation monitoring and assay development.
Meet the Sponsor
Using Antigen Test or PCR tests? Different technologies bringing complementary answers.
Date & Time: Monday 15 February 12:00 - 12:45 EST (18:00 - 18:45 CET)
Speakers:
![](https://www2.orthoclinicaldiagnostics.com/l/417052/2021-02-08/615w7v/417052/1612797121CnT1Wh1I/speaker_cecilia.jpg)
Cecilia Scarponi
EMEA Clinical Liaison at Ortho Clinical Diagnostics.
![](https://www2.orthoclinicaldiagnostics.com/l/417052/2021-02-08/615w7s/417052/1612797121dHyUml5e/speaker_els.jpg)
Els Melis
EMEA Senior Marketing Manager at Ortho Clinical Diagnostics.
Posters
1. Title: Development of the CE-marked VITROS® SARS-CoV-2 Antigen Immunoassay: A Viable Test for the Diagnosis of Symptomatic and Asymptomatic Individuals.
Authors: Sierra L. Clark, Amelia Brunner, Paul Contestable, and Charles A. Noeson
Ortho Clinical Diagnostics
2. Title: Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 Antigen Implications for clinical use.
Authors: Slim Fourati1,2, Alexandre Soulier 1,2, Aurélie Gourgeon1 , Souraya Khouider1 , Camille Langlois1 , Arnaud Galbin1 , Anne Le Bouter1 , Dominique Challine1,2, Magali Bouvier-Alias1,2 , Stéphane Chevaliez1,2, Étienne Audureau2,3, Jean-Michel Pawlotsky1,2
1 Department of Virology, Henri Mondor Hospital, AP-HP (Assistance Publique-Hôpitaux de Paris), Université Paris-Est, F-94010 Créteil, France
2 INSERM U955, Institut Mondor de Recherche Biomédicale, F-94010 Créteil, France
3 Department of Public Health and CEpiA Team, Henri Mondor Hospital, AP-HP (Assistance Publique-Hôpitaux de Paris), Université Paris-Est, F-94010 Creteil, France.